Neuropsychological function and Apolipoprotein E genotype in the preclinical detection of Alzheimer's disease
Neuropsychological function and Apolipoprotein E genotype in the preclinical detection of Alzheimer's disease
复制标题
DOI:
10.1037/0882-7974.14.2.295
复制
发表时间:
1999-06-01
影响因子:
3.7
通讯作者:
Thal, LJ
中科院分区:
文献类型:
--
作者:
Bondi, MW;Salmon, DP;Thal, LJ
Nondemented older adults genotyped for the Apolipoprotein E (ApoE) epsilon 4 allele (n = 43) were neuropsychologically compared to participants without a copy of the epsilon 4 allele (n = 90). At baseline, the groups did not differ on age, education, gender, or global cognitive status. ApoE-epsilon 4 participants demonstrated significantly poorer mean performances on delayed recall, but no significant group differences emerged on attention, language, constructional skills, psychomotor speed, or executive function. Significantly more ApoE-epsilon 4 participants developed probable or questionable Alzheimer's disease (AD) compared with non-epsilon 4 participants, suggesting that the group differences resulted from a preponderance of preclinical AD cases within the epsilon 4 group and not from a direct influence of ApoE genotype on cognition. Cox proportional hazards analysis, adjusting for age, years of education, and global cognitive status, revealed that ApoE-epsilon 4 allele status and measures of recall performance were significant and independent predictors of conversion to AD. Results support the importance of specific episodic memory changes and possession of the ApoE-epsilon 4 allele in the preclinical detection of AD.